ACLX
ACLX
NASDAQ · Biotechnology

Arcellx Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$114.69
+0.09 (+0.08%)
As of Mar 24, 9:57 PM ET ·
Analyst Consensus
Hold
24
Analysts
High
Coverage
Buy 8 33%
Hold 16 67%
Sell 0 0%
Price Target
Analyst Price Target -15.5% upside
Low Target $73.10
Average Target $96.95
High Target $131.09
Current Price $114.69
Current
$114.69
Target
$96.95
$73.10 $96.95 avg $131.09
Scenario Analysis
Bear Case
$73.10
-36.3%
Low target
Base Case
$96.95
-15.5%
Avg target
Bull Case
$131.09
+14.3%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$94.07
21.9% from high
52-Week Low
$47.86
+139.6% from low
50-Day SMA
$67.56
+69.8% vs SMA
200-Day SMA
$71.93
+59.4% vs SMA
RSI (14)
44.8
Neutral
Target vs 52W High
$96.95
+3.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%